r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

TC

Terrie Curran

Insider · Director · ARQT

Terrie Curran files insider transactions with the SEC as a director of Arcutis Biotherapeutics (ARQT). We hold 2 disclosed purchases and sales filed since 17 November 2016, 2 of them in the last 90 days.

  • Files forARQT
  • Disclosed buys and sells2 in all, 2 in the last 90 days
  • Last disclosure28 August 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 2 November 2020 — 27 August 2026Director · Arcutis Biotherapeutics (ARQT)22 Form 4 lines · source: SEC Form 4
  • Filed 1 July 2020 — 27 February 2025President and Chief Executive · Phathom Pharmaceuticals (PHAT)26 Form 4 lines · source: SEC Form 4
  • Filed 15 November 2016 — 10 March 2023Director · Myovant Sciences (MYOV)25 Form 4 lines · source: SEC Form 4
  • Filed 31 July 2017 — 20 November 2019Pres., Glbl Inflam. and Immun. · Celgene Corp /de/ (CELG)64 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.